Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Macrocycles provide an attractive modality for drug development but the identification of ligands to targets of interest is hindered by the lack of large macrocyclic compound libraries for high-throughput screening. A strategy to efficiently synthesize large numbers of macrocyclic compounds is based on the cyclization of peptides having thiol groups at both ends (dithiol peptides) by bis-electrophile reagents. Herein, I have established a strategy to produce macrocyclic compounds at high-throughput in a 96-well format, comprising the steps of i) peptide synthesis on solid phase immobilized via a disulfide bridge, ii) side-chain deprotection on solid phase, iii) reductive peptide release from solid phase, iv) removal of reducing agent by evaporation, and v) cyclization of the peptides by addition of bis-electrophiles. In contrast to a related strategy for dithiol peptide synthesis based on cyclative release, the new strategy allows for the synthesis of particularly short dithiol peptides and thus accessing macrocycles smaller than 600 Da that are attractive for the development of orally available and/or cell permeable drugs.
Christian Heinis, Alexander Lund Nielsen, Sevan Mleh Habeshian, Gontran Sangouard, Edward Jeffrey Will, Anne Sofie Luise Zarda
Christian Heinis, Alexander Lund Nielsen, Manuel Leonardo Merz, Xinjian Ji, Ganesh Kumar Mothukuri, Anne Sofie Luise Zarda, Zsolt Bognár
Christoph Merten, Leonie Kolmar, Xiaoli Ma, Hongxing Hu